Company / Operating Income per Share
Protagonist Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.49
FY2025
5-year range
-$2.72 / $3.89
FY2021-FY2025
Trend
-164.0%
vs FY2024
Sector context
#129 of 201
Health Care
What the data says
At $-2.49, Protagonist Therapeutics, Inc.'s operating income per share ranks #129 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-5.02 in FY2016 to $3.89 in FY2024.
Based on SEC 10-K filings.
-2.49 in FY2025.
Declined from $-1.65 to $-2.49 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#129 of 201 in Health CareTop 64% of 201This company -$2.49 Sector average -$28.56
▼
+91.3% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 164.0% year-over-year.
- Ranks #129 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.49 | -164.0% |
| FY2024 | $3.89 | +335.5% |
| FY2023 | -$1.65 | +38.4% |
| FY2022 | -$2.68 | +1.4% |
| FY2021 | -$2.72 | -44.8% |
| FY2020 | -$1.88 | +39.7% |
| FY2019 | -$3.11 | -64.5% |
| FY2018 | -$1.89 | +11.8% |
| FY2017 | -$2.14 | +57.4% |
| FY2016 | -$5.02 | +91.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026